Clinical trial site

Osaka-shi Osaka, Kansai 530-0002

0 studies enrolling now · 1 studies all time

What they study most

Cytomegalovirus Infection

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early